Delivery Order SPE2DB24D2013-SPE2DB24FCGXF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,984.38 firm-fixed-price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of January 17, 2023. This award is associated with AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Micardis HCT 40-12.5 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,398.33 and a completion date of December 10, 2024. The contract is not designated with a set-aside. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,599.04 fixed-price delivery order is for MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of November 21, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Micardis HCT 80-25 mg tablet units. The contract has a ceiling value of $12,617.56 and runs through November 2, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,069.39 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,336.09 firm fixed-price delivery order contract is for the supply of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,289.61 and is for the delivery of MICARDIS HCT 80-12.5 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of September 29, 2023 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,315.38 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,677.16, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract provides MICARDIS HCT 80-12.5 MG TABLET UD 30S, a pharmaceutical product, with an ultimate completion date of July 19, 2024. The contract was not set aside for any specific business category....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.02 firm fixed-price delivery order is for the supply of Micardis HCT 80-12.5 mg tablets, a hypertension medication, with a completion date of May 7, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB24FCGXFDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of MICARDIS HCT 80-12.5 mg tablets. The $10,954.37 firm-fixed-price delivery order has a completion date of May 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 5/23/24 |